Eyenovia Stock to Reverse Split on Monday, February 3rd (NASDAQ:EYEN)

Shares of Eyenovia, Inc. (NASDAQ:EYEN) are scheduled to reverse split on the morning of Monday, February 3rd. The 1-80 reverse split was announced on Tuesday, January 28th. The number of shares owned by shareholders will be adjusted after the market closes on Friday, January 31st.

Eyenovia Stock Performance

Shares of Eyenovia stock opened at $0.04 on Thursday. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.55 and a current ratio of 0.74. Eyenovia has a 1 year low of $0.04 and a 1 year high of $2.57. The firm’s 50-day simple moving average is $0.09 and its 200-day simple moving average is $0.46. The firm has a market cap of $4.15 million, a PE ratio of -0.05 and a beta of 1.31.

Eyenovia (NASDAQ:EYEN) last announced its quarterly earnings data on Tuesday, November 12th. The company reported ($0.11) earnings per share for the quarter, beating the consensus estimate of ($0.13) by $0.02. Eyenovia had a negative return on equity of 1,108.24% and a negative net margin of 114,639.41%. During the same period last year, the company earned ($0.18) earnings per share. Equities analysts forecast that Eyenovia will post -0.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on EYEN shares. LADENBURG THALM/SH SH restated a “neutral” rating on shares of Eyenovia in a research note on Monday, November 18th. Brookline Capital Management restated a “hold” rating on shares of Eyenovia in a research report on Friday, November 15th. William Blair reaffirmed a “market perform” rating on shares of Eyenovia in a research report on Friday, November 15th. Finally, HC Wainwright cut shares of Eyenovia from a “buy” rating to a “neutral” rating and cut their target price for the stock from $12.00 to $2.00 in a report on Monday, November 18th.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the stock. Nations Financial Group Inc. IA ADV raised its holdings in shares of Eyenovia by 78.6% during the third quarter. Nations Financial Group Inc. IA ADV now owns 90,900 shares of the company’s stock valued at $47,000 after buying an additional 40,000 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Eyenovia in the 2nd quarter valued at approximately $26,000. Financial Management Network Inc. acquired a new stake in Eyenovia in the 3rd quarter valued at approximately $39,000. Finally, Geode Capital Management LLC raised its stake in Eyenovia by 36.6% during the 3rd quarter. Geode Capital Management LLC now owns 557,994 shares of the company’s stock valued at $288,000 after acquiring an additional 149,471 shares in the last quarter. 25.84% of the stock is currently owned by institutional investors.

Eyenovia Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.